Skip to main content

Together we are beating cancer

Donate now

Radiotherapy

Showing 12 out of 188 results
Cancer Research UK logo

A single injection of carboplatin - a chemotherapy drug commonly used to treat ovarian and lung cancer - can replace radiotherapy to cure a common type of testicular cancer, according to results presented at the National Cancer Research Institute (NCRI) Cancer Conference in Birmingham today (Monday). A single injection of carboplatin - a chemotherapy drug commonly used to treat ovarian and lung cancer - can replace radiotherapy to cure a common type of testicular cancer, according to results presented at the National Cancer Research Institute (NCRI) Cancer Conference in Birmingham today (Monday).

by Cancer Research UK | News | 6 October 2008

6 October 2008

Cancer Research UK logo

Using chemotherapy to delay or avoid radiotherapy in children under three with a type of brain tumour called ependymoma reduces the risk of potentially damaging long term side effects, reveal trial results published online in the Lancet Oncology. Using chemotherapy to delay or avoid radiotherapy in children under three with a type of brain tumour called ependymoma reduces the risk of potentially damaging long term side effects, reveal trial results published online in the Lancet Oncology.

by Cancer Research UK | News | 21 July 2007

21 July 2007

Cancer Research UK logo

Cancer patients about to undergo pelvic radiotherapy or who have had the treatment and are experiencing some of the potentially worrying and embarrassing side effects, now have a new free resource to turn to thanks to Cancerbackup and Cancer Research UK. Cancer patients about to undergo pelvic radiotherapy or who have had the treatment and are experiencing some of the potentially worrying and embarrassing side effects, now have a new free resource to turn to thanks to Cancerbackup and Cancer Research UK.

by Cancer Research UK | News | 29 May 2007

29 May 2007

Cancer Research UK logo

Giving breast cancer patients fewer but larger doses of radiotherapy may be as safe and as effective at reducing the risk of cancer returning, according to Cancer Research UK trial results published in todayїs (Tuesday 30 May) Lancet Oncology. Giving breast cancer patients fewer but larger doses of radiotherapy may be as safe and as effective at reducing the risk of cancer returning, according to Cancer Research UK trial results published in todayїs (Tuesday 30 May) Lancet Oncology.

by Cancer Research UK | News | 29 May 2006

29 May 2006

Cancer Research UK logo

Gene therapy could be used to shield important healthy stem cells of cancer patients during radiotherapy, enabling stronger doses to be administered safely, according to a report published today in the Journal of Gene Medicine. Gene therapy could be used to shield important healthy stem cells of cancer patients during radiotherapy, enabling stronger doses to be administered safely, according to a report published today in the Journal of Gene Medicine.

by Cancer Research UK | News | 27 February 2006

27 February 2006

Cancer Research UK logo

Following a lumpectomy for breast cancer, radiotherapy to the breast reduces the risk of eventually dying from the disease - according to research published in todayїs (Friday 16 December 2005) The Lancet. Following a lumpectomy for breast cancer, radiotherapy to the breast reduces the risk of eventually dying from the disease - according to research published in todayїs (Friday 16 December 2005) The Lancet.

by Cancer Research UK | News | 16 December 2005

16 December 2005

Cancer Research UK logo

Major advances in the treatment of cancer with radiotherapy were forecast today (Thursday 10th November 2005) by a leading Oxford cancer expert. Major advances in the treatment of cancer with radiotherapy were forecast today (Thursday 10th November 2005) by a leading Oxford cancer expert.

by Cancer Research UK | News | 10 November 2005

10 November 2005

Cancer Research UK logo

A simple test to predict how well bladder cancers will respond to radiotherapy could enable doctors to tailor the best treatment for their patients, according to a study published today. A simple test to predict how well bladder cancers will respond to radiotherapy could enable doctors to tailor the best treatment for their patients, according to a study published today.

by Cancer Research UK | News | 1 September 2005

1 September 2005